Market Overview:
The global oxyclozanide market is expected to grow at a CAGR of 3.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for oxyclozanide in feed additives and oral liquids applications. Additionally, the growing awareness about animal health and hygiene is also propelling the growth of this market. However, stringent regulatory norms regarding animal safety may restrain the growth of this market during the forecast period. On the basis of type, content 98% held a major share of the global oxyclozanide market in 2017 and is projected to maintain its dominance duringthe forecast period as well. This can be attributed to its high efficacy against various parasites affecting animals.
Product Definition:
A synthetic, broad-spectrum anthelmintic agent used to treat a variety of parasitic worm infestations in animals.
Content 98%:
The Content 98% is a patented form of the active pharmaceutical ingredient (API) developed by Pfizer, Inc. for the treatment of malaria. It is an extremely potent and pure form of API used in the manufacturing process of various antimalarial medications such as Oxyclozanide.
Oxyclozanide has been approved by WHO and EMEA to be used along with other therapies for P.
Content 99%:
It is a chemical that helps in controlling the population of bacteria and other microorganisms. It belongs to the class of chemicals known as disinfectants or antiseptics. Content 99% is used for killing viruses, bacteria, and germs which are believed to be responsible for causing diseases. The product has been approved by the U.
Application Insights:
Injectables were the major application segment and accounted for more than 60% of the global share in terms of revenue in 2017. The product is used as an antiseptic and disinfectant for various parts of human body, including skin, eyes, ears, nose & mouth. It is also used to treat infections caused by bacteria or fungi that are present within the cells or on the surface of human body tissues or organs.
Oral liquids are expected to witness significant growth over forecast period owing to their rising use as a food additive across the globe particularly in Europe and North America regions.
Regional Analysis:
Asia Pacific was the largest market for oxoclastazone and accounted for a revenue share of over 45% in 2017. The region is expected to continue its dominance over the forecast period as well due to high product demand from countries such as China, India, Japan, South Korea and Taiwan. Increasing meat consumption coupled with rising healthcare expenditure by consumers is projected to be a key factor driving regional growth.
The growing pharmaceutical industry in emerging economies such as China and India are likely to contribute significantly towards increasing product consumption in injectable drugs applications while expanding the scope of this compound across various other industries including feed additives will fuel its growth further. In addition, favorable regulations aimed at promoting investments by domestic manufacturers are anticipated to boost market penetration rates during the forecast period.
Growth Factors:
- Increasing prevalence of parasitic infections: The increasing prevalence of parasitic infections is one of the major growth drivers for the oxyclozanide market. According to a study by the World Health Organization (WHO), there were approximately 2 billion cases of malaria, schistosomiasis, and soil-transmitted helminthiasis in 2015. This number is expected to increase in the coming years due to the increasing population and changing lifestyle habits.
- Rising demand for novel anti-parasitic drugs: The growing demand for novel anti-parasitic drugs is another key factor driving the growth of the oxyclozanide market. Oxyclozanide is a relatively new drug that has shown promising results against various parasites such as Schistosoma mansoni, Plasmodium falciparum, and Trichomonas vaginalis. This is likely to boost its adoption in future years.
- Growing awareness about parasitic diseases: There has been a growing awareness about parasitic diseases in recent years owing to initiatives by various organizations such as WHO and Centers for Disease Control and Prevention (CDC). This has led to an increase in demand for effective anti-parasitic drugs such as oxyclozanide worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxyclozanide Market Research Report
By Type
Content 98%, Content 99%, Other
By Application
Injectables, Oral Liquids, Feed Additives
By Companies
Siflon Drugs, Yabang, Gharda, ASCENT PHARMA, Aarambh Life Science, ProVentus, Excel Industries, Konar Organics, Neha Pharma, D. H. Organics, Neeta Interchem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Oxyclozanide Market Report Segments:
The global Oxyclozanide market is segmented on the basis of:
Types
Content 98%, Content 99%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Injectables, Oral Liquids, Feed Additives
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siflon Drugs
- Yabang
- Gharda
- ASCENT PHARMA
- Aarambh Life Science
- ProVentus
- Excel Industries
- Konar Organics
- Neha Pharma
- D. H. Organics
- Neeta Interchem
Highlights of The Oxyclozanide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Content 98%
- Content 99%
- Other
- By Application:
- Injectables
- Oral Liquids
- Feed Additives
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxyclozanide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxyclozanide is a medication used to treat bladder cancer. It works by blocking the growth of new tumors in the bladder. Oxyclozanide is usually given as an injection into a vein.
Some of the major companies in the oxyclozanide market are Siflon Drugs, Yabang, Gharda, ASCENT PHARMA, Aarambh Life Science, ProVentus, Excel Industries, Konar Organics, Neha Pharma, D. H. Organics, Neeta Interchem.
The oxyclozanide market is expected to register a CAGR of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oxyclozanide Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oxyclozanide Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oxyclozanide Market - Supply Chain
4.5. Global Oxyclozanide Market Forecast
4.5.1. Oxyclozanide Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oxyclozanide Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oxyclozanide Market Absolute $ Opportunity
5. Global Oxyclozanide Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oxyclozanide Market Size and Volume Forecast by Type
5.3.1. Content 98%
5.3.2. Content 99%
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oxyclozanide Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oxyclozanide Market Size and Volume Forecast by Application
6.3.1. Injectables
6.3.2. Oral Liquids
6.3.3. Feed Additives
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oxyclozanide Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oxyclozanide Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oxyclozanide Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oxyclozanide Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oxyclozanide Demand Share Forecast, 2019-2026
9. North America Oxyclozanide Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oxyclozanide Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oxyclozanide Market Size and Volume Forecast by Application
9.4.1. Injectables
9.4.2. Oral Liquids
9.4.3. Feed Additives
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oxyclozanide Market Size and Volume Forecast by Type
9.7.1. Content 98%
9.7.2. Content 99%
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oxyclozanide Demand Share Forecast, 2019-2026
10. Latin America Oxyclozanide Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oxyclozanide Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oxyclozanide Market Size and Volume Forecast by Application
10.4.1. Injectables
10.4.2. Oral Liquids
10.4.3. Feed Additives
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oxyclozanide Market Size and Volume Forecast by Type
10.7.1. Content 98%
10.7.2. Content 99%
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oxyclozanide Demand Share Forecast, 2019-2026
11. Europe Oxyclozanide Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oxyclozanide Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oxyclozanide Market Size and Volume Forecast by Application
11.4.1. Injectables
11.4.2. Oral Liquids
11.4.3. Feed Additives
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oxyclozanide Market Size and Volume Forecast by Type
11.7.1. Content 98%
11.7.2. Content 99%
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oxyclozanide Demand Share, 2019-2026
12. Asia Pacific Oxyclozanide Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oxyclozanide Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oxyclozanide Market Size and Volume Forecast by Application
12.4.1. Injectables
12.4.2. Oral Liquids
12.4.3. Feed Additives
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oxyclozanide Market Size and Volume Forecast by Type
12.7.1. Content 98%
12.7.2. Content 99%
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oxyclozanide Demand Share, 2019-2026
13. Middle East & Africa Oxyclozanide Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oxyclozanide Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oxyclozanide Market Size and Volume Forecast by Application
13.4.1. Injectables
13.4.2. Oral Liquids
13.4.3. Feed Additives
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oxyclozanide Market Size and Volume Forecast by Type
13.7.1. Content 98%
13.7.2. Content 99%
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oxyclozanide Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oxyclozanide Market: Market Share Analysis
14.2. Oxyclozanide Distributors and Customers
14.3. Oxyclozanide Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Siflon Drugs
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Yabang
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Gharda
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ASCENT PHARMA
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Aarambh Life Science
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ProVentus
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Excel Industries
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Konar Organics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Neha Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. D. H. Organics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Neeta Interchem
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook